CRS: Whitman-Walker
Position: Pharmacist of Record
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
